Literature DB >> 7806018

Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids.

C D Byrne1, N J Wareham, D C Brown, P M Clark, L J Cox, N E Day, C R Palmer, T W Wang, D R Williams, C N Hales.   

Abstract

Although plasma insulin and triglyceride concentrations are positively correlated in many studies, the relationships between insulin resistance, insulin secretion and hypertriglyceridaemia remain unclear. To study these associations, subjects between the ages of 40 and 64 were randomly selected from a general practice register and invited to attend for a standard oral glucose tolerance test for measurement of insulin, triglyceride and non-esterified fatty acid concentrations. The study comprised 1122 subjects who were not previously known to have diabetes and who completed the test. Using the World Health Organisation criteria, 51 subjects were classified to have non-insulin-dependent diabetes mellitus, 188 had impaired glucose tolerance and 883 subjects had normal glucose tolerance. Triglyceride concentrations in subjects with glucose intolerance were elevated compared to those in control subjects, even after adjustment for age, obesity and gender (p < 0.001 for subjects with diabetes and p < 0.01 for those with impaired glucose tolerance compared to normal subjects). In separate multiple regression analyses for males and females, the most important determinants of the plasma triglyceride concentration were the area under the non-esterified fatty acid suppression curve (p < 0.001 in both genders) and the waist-hip ratio (p < 0.001 for men and < 0.01 for women). The fasting insulin concentration was independently associated with triglyceride concentration in women only (p < 0.01). The most important determinant of the area under the non-esterified fatty acid suppression curve in men was the 30-min insulin increment, a measure of insulin secretion, (p < 0.001) whereas for women age (p < 0.001) and the body mass index (p < 0.01) were the most important.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7806018     DOI: 10.1007/bf00400944

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  47 in total

1.  Enzymatic determination of serum-free fatty acids: a colorimetric method.

Authors:  S Shimizu; Y Tani; H Yamada; M Tabata; T Murachi
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

2.  Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia.

Authors:  H Yki-Järvinen; M R Taskinen
Journal:  Diabetes       Date:  1988-09       Impact factor: 9.461

3.  Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes.

Authors:  P N Durrington; R S Newton; D B Weinstein; D Steinberg
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

4.  Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

Authors:  W B Kannel
Journal:  Am Heart J       Date:  1985-11       Impact factor: 4.749

Review 5.  Hypertriglyceridemia: risks and perspectives.

Authors:  A M Gotto
Journal:  Am J Cardiol       Date:  1992-12-14       Impact factor: 2.778

6.  Oleic acid promotes the activation and translocation of phosphatidate phosphohydrolase from the cytosol to particulate fractions of isolated rat hepatocytes.

Authors:  C Cascales; E H Mangiapane; D N Brindley
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

7.  Effects of cyclic AMP, glucocorticoids and insulin on the activities of phosphatidate phosphohydrolase, tyrosine aminotransferase and glycerol kinase in isolated rat hepatocytes in relation to the control of triacylglycerol synthesis and gluconeogenesis.

Authors:  R A Pittner; R Fears; D N Brindley
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

8.  The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.

Authors:  G Assmann; H Schulte
Journal:  Am Heart J       Date:  1988-12       Impact factor: 4.749

9.  Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance.

Authors:  M J Davies; G Rayman; I P Gray; J L Day; C N Hales
Journal:  Diabet Med       Date:  1993-05       Impact factor: 4.359

10.  Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type 2 diabetes mellitus.

Authors:  M J Davies; J Metcalfe; I P Gray; J L Day; C N Hales
Journal:  Diabet Med       Date:  1993-05       Impact factor: 4.359

View more
  17 in total

1.  Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program.

Authors:  Jose C Florez; Kathleen A Jablonski; Steven E Kahn; Paul W Franks; Dana Dabelea; Richard F Hamman; William C Knowler; David M Nathan; David Altshuler
Journal:  Diabetes       Date:  2007-02       Impact factor: 9.461

2.  Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans.

Authors:  Erik Ingelsson; Claudia Langenberg; Marie-France Hivert; Inga Prokopenko; Valeriya Lyssenko; Josée Dupuis; Reedik Mägi; Stephen Sharp; Anne U Jackson; Themistocles L Assimes; Peter Shrader; Joshua W Knowles; Björn Zethelius; Fahim A Abbasi; Richard N Bergman; Antje Bergmann; Christian Berne; Michael Boehnke; Lori L Bonnycastle; Stefan R Bornstein; Thomas A Buchanan; Suzannah J Bumpstead; Yvonne Böttcher; Peter Chines; Francis S Collins; Cyrus C Cooper; Elaine M Dennison; Michael R Erdos; Ele Ferrannini; Caroline S Fox; Jürgen Graessler; Ke Hao; Bo Isomaa; Karen A Jameson; Peter Kovacs; Johanna Kuusisto; Markku Laakso; Claes Ladenvall; Karen L Mohlke; Mario A Morken; Narisu Narisu; David M Nathan; Laura Pascoe; Felicity Payne; John R Petrie; Avan A Sayer; Peter E H Schwarz; Laura J Scott; Heather M Stringham; Michael Stumvoll; Amy J Swift; Ann-Christine Syvänen; Tiinamaija Tuomi; Jaakko Tuomilehto; Anke Tönjes; Timo T Valle; Gordon H Williams; Lars Lind; Inês Barroso; Thomas Quertermous; Mark Walker; Nicholas J Wareham; James B Meigs; Mark I McCarthy; Leif Groop; Richard M Watanabe; Jose C Florez
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

3.  Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.

Authors:  Jose C Florez; Kathleen A Jablonski; Maria W Sun; Nick Bayley; Steven E Kahn; Harry Shamoon; Richard F Hamman; William C Knowler; David M Nathan; David Altshuler
Journal:  J Clin Endocrinol Metab       Date:  2007-01-09       Impact factor: 5.958

4.  Short-term sprint interval training increases insulin sensitivity in healthy adults but does not affect the thermogenic response to beta-adrenergic stimulation.

Authors:  Jennifer C Richards; Tyler K Johnson; Jessica N Kuzma; Mark C Lonac; Melani M Schweder; Wyatt F Voyles; Christopher Bell
Journal:  J Physiol       Date:  2010-06-14       Impact factor: 5.182

5.  Insulin-mediated FFA suppression is associated with triglyceridemia and insulin sensitivity independent of adiposity.

Authors:  Nikki C Bush; Rita Basu; Robert A Rizza; K Sreekumaran Nair; Sundeep Khosla; Michael D Jensen
Journal:  J Clin Endocrinol Metab       Date:  2012-08-29       Impact factor: 5.958

6.  Factors affecting the decline in incidence of diabetes in the Diabetes Prevention Program Outcomes Study (DPPOS).

Authors:  Richard F Hamman; Edward Horton; Elizabeth Barrett-Connor; George A Bray; Costas A Christophi; Jill Crandall; Jose C Florez; Sarah Fowler; Ronald Goldberg; Steven E Kahn; William C Knowler; John M Lachin; Mary Beth Murphy; Elizabeth Venditti
Journal:  Diabetes       Date:  2014-10-02       Impact factor: 9.461

Review 7.  Mechanism of differential effects of antihypertensive agents on serum lipids.

Authors:  R D Brook
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

8.  Gender differences in regional fatty acid metabolism before and after meal ingestion.

Authors:  M D Jensen
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2).

Authors:  A Ramachandran; C Snehalatha; S Mary; S Selvam; C K S Kumar; A C Seeli; A S Shetty
Journal:  Diabetologia       Date:  2009-03-10       Impact factor: 10.122

10.  Decreased non-esterified fatty acid suppression and features of the insulin resistance syndrome occur in a sub-group of individuals with normal glucose tolerance.

Authors:  C D Byrne; N J Wareham; N E Day; R McLeish; D R Williams; C N Hales
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.